RenovoRx: Funding, Investors & Team (Oct 2026)
RenovoRx is creating cutting-edge solutions for precise delivery of fluids, such as diagnostic and therapeutic agents, to specific areas in the peripheral vascular system. The company has received FDA approval for their RenovoCath™ RC120 and is currently introducing this advanced technology into the clinical market. RenovoRx has a dedicated Management Team with extensive experience and a promising outlook for the future of targeted delivery. The company also benefits from a diverse Advisory Board composed of interventional radiologists, surgical oncologists, and gastroenterologists who provide guidance on clinical development strategies. Supported by a committed Board of Directors, RenovoRx has the expertise and vision necessary for long-term success in the medical and biotechnology industries.
RenovoRx has raised $21.1M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Mar 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RenovoRx Company Profile and Key Stats
Latest funding round on record: Mar 2026.
RenovoRx Funding Rounds
RenovoRx raised $11.1M in an undisclosed round announced in Apr 2024.
1.9 years later, an undisclosed round of $10.0M was announced in Mar 2026.
RenovoRx Founders and Leadership Team
Contact details for the RenovoRx team: 1 has a LinkedIn profile.
Start 14-day free trial →RenovoRx Funding Compared to Other Biotechnology Startups
RenovoRx's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RenovoRx in Biotechnology and Los Altos
Companies Similar to RenovoRx
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
RenovoRx Funding FAQs
What does RenovoRx do?
RenovoRx is creating cutting-edge solutions for precise delivery of fluids, such as diagnostic and therapeutic agents, to specific areas in the peripheral vascular system. The company has received FDA approval for their RenovoCath™ RC120 and is currently introducing this advanced technology into the clinical market. RenovoRx has a dedicated Management Team with extensive experience and a promising outlook for the future of targeted delivery. The company also benefits from a diverse Advisory Board composed of interventional radiologists, surgical oncologists, and gastroenterologists who provide guidance on clinical development strategies. Supported by a committed Board of Directors, RenovoRx has the expertise and vision necessary for long-term success in the medical and biotechnology industries.
How much funding has RenovoRx raised?
RenovoRx has raised $21.1M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Mar 2026.
When did RenovoRx last raise funding?
RenovoRx's most recent funding round on record is an undisclosed round of $10.0M, announced in Mar 2026.
Who founded RenovoRx?
FundedIQ lists Kamran Najmabadi (Founder), Shaun R Bagai (Founder) at RenovoRx.
Where is RenovoRx headquartered?
RenovoRx is based in Los Altos, California, United States.
How many employees does RenovoRx have?
RenovoRx is in the 11-50 employee band.
How does RenovoRx's funding compare to other Biotechnology startups?
RenovoRx's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's RenovoRx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RenovoRx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.